MyoKardia Stock News

DCM Announces Second Quarter 2020 Results

Near-Term Focus on Pursuing Approval of Mavacamten for Obstructive HCM Innovative Model Focused on Long-Term Value Creation:  MyoKardia Receives Equity Position in Lian Cardiovascular and Tassos Gi

Virtual Analyst and Investor Event to Review Data Planned for 8:00 a.m. EDT on August 31BRISBANE, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today announced that the comp

Nisa Investment Advisors LLC grew its holdings in shares of Myokardia Inc (NASDAQ:MYOK) by 25.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange

SG Americas Securities LLC reduced its position in Myokardia Inc (NASDAQ:MYOK) by 64.7% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The i

BRISBANE, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today announced that Jake Bauer, Chief Business Officer, will present at the 2020 Wedbush PacGrow Healthcare Virtual

MYOK earnings call for the period ending June 30, 2020.

Creative Planning acquired a new position in shares of Myokardia Inc (NASDAQ:MYOK) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commi

BRISBANE, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today reported financial results for the second quarter ended June 30, 2020. “The second quarter of 2020 was one

MyoKardia reports initiating trial for invasive septal reduction therapy. Aileron completes enrollment in chemotherapeutic agent trial.

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) ABIOMED, Inc. (NASDAQ: ABMD) ALX Oncology Holdings Inc (NASDAQ: ALXO) Annexon Inc (NASDAQ: ANNX) Atossa...

VALOR-HCM Designed to Generate Direct Evidence of Improved Outcomes for People with HCM by Reducing the Need for Invasive Septal Reduction TherapyBRISBANE, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE)

VALOR-HCM Designed to Generate Direct Evidence of Improved Outcomes for People with HCM by Reducing the Need for Invasive Septal Reduction TherapyBRISBANE, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE)

Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flow continued to pour in,...

BRISBANE, Calif., July 28, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced that it will report second quarter financial and operating results on Tuesday, August 4, 2020. Manag